Abstract
Prognostic Utility of a Novel Prognostic Model Consisting of Age, CRP, Ki67, and POD24 in Patients with Angioimmunoblastic T-Cell Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have